Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|16|1831-1843

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.16, 2015-12, pp. : 1831-1843

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PTEN Loss-Mediated Akt Activation Increases the Properties of Cancer Stem-Like Cell Populations in Prostate Cancer

By  

Oncology, Vol. 87, Iss. 5, 2014-08 ,pp. : 270-279

Karger

Access to resources Recommend Favorite

Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3‐AR axis inhibition

By  

THE PROSTATE, Vol. 75, Iss. 13, 2015-09 ,pp. : 1341-1353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variant allele of HSD3B1 increases progression to castration‐resistant prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 7, 2015-05 ,pp. : 777-782

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prostate Volume Index and Chronic Inflammation of the Prostate Type IV with Respect to the Risk of Prostate Cancer

By  

Urologia Internationalis, Vol. 94, Iss. 3, 2014-08 ,pp. : 270-285

Karger

Access to resources Recommend Favorite

Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration‐resistant prostate cancer

By  

THE PROSTATE, Vol. 73, Iss. 12, 2013-09 ,pp. : 1291-1305

John Wiley & Sons Inc

Access to resources Recommend Favorite